novel agents for the treatment of hodgkin lymphoma: brentuximab vedotin and nivolumab
Published 3 months ago • 113 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
1:09
novel immunotherapy combinations in hodgkin lymphoma
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:59
hodgkin lymphoma: prognostic markers in the era of novel treatments
-
0:51
the need for novel agents for the treatment of ptcl
-
1:10
upcoming novel agents for the treatment of sickle cell disease
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
40:46
novel therapeutics
-
5:35
lymphoma - dr.rahul bhargava
-
18:51
is there scientific proof we can heal ourselves? | lissa rankin, md | tedxamericanriviera
-
1:36
the use of outpatient cilta-cel in the treatment of multiple myeloma
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:50
novel treatment regimens under investigation for richter's transformation
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
4:43
novel treatments being explored for patients with hemophilia: highlights from isth 2024
-
5:08
novel agents for hl
-
7:45
novel targets and agents for lymphoma
-
1:18
targeted therapies in r/r myeloma: novel approaches being explored
-
2:57
moving away from chemoimmunotherapy and towards novel targeted agents in cll
-
3:24
novel agents for the management of r/r myeloma
-
2:15
hovon/llpc transplant brave: novel salvage chemotherapy for r/r hodgkin lymphoma